Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Top 20 Wellbeing and Wellness Applications for a Sound Way of life - 2South America's Memorable Destinations: A Movement Guide
- 310 Picturesque Campgrounds That Will Raise Your Outside Involvement with American
- 4Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
- 52 new malaria treatments announced as drug resistance grows
- Norovirus is spreading earlier again this year, wastewater data shows
- vote in favor of Your #1 kind of climate
- 5 Movies That Leaving an Imprint with Inventive Innovation
- The Force of Care: Living with Goal
- Mont Blanc road tunnel reopens to traffic after 15 weeks of repairs
- Instructions to Explore the Therapy Choices for Cellular breakdown in the lungs
- Lily Allen 2026 'West End Girl' Tour: How to get tickets, prices, presale info and more
- Careful Nurturing: Techniques for Bringing up Tough Children
- Presenting Nintendo's New Pastel Bliss Con Tones for Switch Gamers: 3 Smart Choices
